Research ArticleBRAIN
Can Tumor Contrast Enhancement Be Used as a Criterion for Differentiating Tumor Grades of Oligodendrogliomas?
Matthew L. White, Yan Zhang, Patricia Kirby and Timothy C. Ryken
American Journal of Neuroradiology April 2005, 26 (4) 784-790;
Matthew L. White
Yan Zhang
Patricia Kirby

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Advertisement
Matthew L. White, Yan Zhang, Patricia Kirby, Timothy C. Ryken
Can Tumor Contrast Enhancement Be Used as a Criterion for Differentiating Tumor Grades of Oligodendrogliomas?
American Journal of Neuroradiology Apr 2005, 26 (4) 784-790;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Prognostic Value of Preoperative MRI Metrics for Diffuse Lower-Grade Glioma Molecular Subtypes
- Improved Brain Tumor Classification by Sodium MR Imaging: Prediction of IDH Mutation Status and Tumor Progression
- Multimodal MR Imaging (Diffusion, Perfusion, and Spectroscopy): Is It Possible to Distinguish Oligodendroglial Tumor Grade and 1p/19q Codeletion in the Pretherapeutic Diagnosis?
- Imaging Characteristics of Oligodendrogliomas That Predict Grade
- Conventional MRI evaluation of gliomas
- Diffusion Tensor MR Imaging of Cerebral Gliomas: Evaluating Fractional Anisotropy Characteristics
- First Experiences with Low-dose Anti-angiogenic Treatment in Gliomatosis Cerebri with Signs of Angiogenic Activity
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement